AJP - Endo AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 284: E830-E840, 2003. First published December 17, 2002; doi:10.1152/ajpendo.00390.2002
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/4/E830    most recent
00390.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kishi, A.
Right arrow Articles by Kashiwagi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kishi, A.
Right arrow Articles by Kashiwagi, A.
Vol. 284, Issue 4, E830-E840, April 2003

Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation

Akio Kishi1, Takaaki Nakamura2, Yoshihiko Nishio1, Hiroshi Maegawa1, and Atsunori Kashiwagi1

Division of Endocrinology and Metabolism, Departments of 1 Medicine and 2 Anatomy, Shiga University of Medical Science, Seta, Otsu, Shiga 520-2192 Japan

Pancreatic duodenal homeobox-1 (Pdx1) is a transcription factor, and its phosphorylation is thought to be essential for activation of insulin gene expression. This phosphorylation is related to a concomitant shift in molecular mass from 31 to 46 kDa. However, we found that Pdx1 was modified by SUMO-1 (small ubiquitin-related modifier 1) in beta -TC-6 and COS-7 cells, which were transfected with Pdx1 cDNA. This modification contributed to the increase in molecular mass of Pdx1 from 31 to 46 kDa. Additionally, sumoylated Pdx1 localized in the nucleus. The reduction of SUMO-1 protein by use of RNA interference (SUMO-iRNAs) resulted in a significant decrease in Pdx1 protein in the nucleus. A 34-kDa form of Pdx1 was detected by the cells exposed to SUMO-iRNAs in the presence of lactacystin, a proteasome inhibitor. Furthermore, the reduced nuclear sumoylated Pdx1 content was associated with significant lower transcriptional activity of the insulin gene. These findings indicate that SUMO-1 modification is associated with both the localization and stability of Pdx1 as well as its effect on insulin gene activation.

small ubiquitin-related modifier 1; pancreatic duodenal homeobox-1; ribonucleic acid interference


This article has been cited by other articles:


Home page
 J. Nutr.Home page
V. Poitout, D. Hagman, R. Stein, I. Artner, R. P. Robertson, and J. S. Harmon
Regulation of the Insulin Gene by Glucose and Fatty Acids
J. Nutr., April 1, 2006; 136(4): 873 - 876.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Li, P. Kessler, H. Yeger, J. Alami, A. E. Reeve, R. Heathcott, J. Skeen, and B. R.G. Williams
A Gene Expression Signature for Relapse of Primary Wilms Tumors
Cancer Res., April 1, 2005; 65(7): 2592 - 2601.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
M. Trajkovski, H. Mziaut, A. Altkruger, J. Ouwendijk, K.-P. Knoch, S. Muller, and M. Solimena
Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in {beta}-cells
J. Cell Biol., December 20, 2004; 167(6): 1063 - 1074.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online